home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Immuno-Oncology: Functional Assays for Immune Checkpoint Inhibitors as Emerging Therapeutics

 
  July 16, 2021  
     
 
Xtalks, Online
2021-07-29


In the immuno-oncology space, the regulation of the immune system is paramount in the development of a successful therapeutic. This webinar will showcase assays to evaluate cellular pathways of immune cells, T-cells, and macrophages while highlighting functional and immunogenicity assays developed in support of current and emerging therapeutics. The speakers, Sofie Pattijn, an immuno-oncology expert who leads the ImmunXperts team in Belgium, and Thibaut Janss, one of their leading expert scientists for immuno-oncology, will outline how in vitro methods mimic the tumor environment to measure therapeutic functionality.

Register for this webinar to hear the speakers highlight how in vitro models are essential at critical phases of development to support lead candidate selection or generate data for evaluation in an exploratory clinical phase. As the development transitions through pre-IND to clinical phases, there are a variety of cellular assays and clinical applications that support the drug development process.

 
 
Organized by: Xtalks
Invited Speakers:

Sofie Pattijn, CTO and Co-Founder, ImmunXperts, a Nexelis Company

Thibaut Janss, Lead Scientist, ImmunXperts, a Nexelis Company

 

 
Deadline for Abstracts: -
 
Registration: Register at Xtalks.
E-mail: jozeph@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.